Keywords: GMM
|
Does Gene Technology Offer Potential to Wipe Out Malaria?Anonymous, AFIDEP, 2021.
The persisting high numbers of Malaria deaths and illnesses mean that the current tools will not get us to zero Malaria. For this reason, experts have continued to explore new tools for Malaria elimination. The gene drive technology is one of the tools being explored for Malaria ... |
|
Proceedings of an expert workshop on community agreement for gene drive research in Africa – Co-organised by KEMRI, PAMCA and Target Malaria [version 1; peer review: awaiting peer review]D. Thizy, L. Pare Toe, C. Mbogo, D. Matoke-Muhia, V. P. Alibu, S. K. Barnhill-Dilling, T. Chantler, G. Chongwe, J. Delborne, L. Kapiriri, E. Nassonko Kavuma, S. Koloi-Keaikitse, A. Kormos, K. Littler, D. Lwetoijera, R. Vargas de Moraes, N. Mumba, L. Muten, Gates Open Research, 2021.
Target Malaria, the Kenya Medical Research Institute and the Pan African Mosquito Control Association co-organised a workshop with researchers and practitioners on this topic to question the model proposed by Target Malaria in its research so far that involved the release of ... |
|
Editorial Expression of Concern: Transgenic Aedes aegypti Mosquitoes Transfer Genes into a Natural PopulationB. R. Evans, P. Kotsakiozi, A. L. Costa-Da-Silva, R. S. Ioshino, L. Garziera, M. C. Pedrosa, A. Malavasi, J. F. Virginio, M. L. Capurro and J. R. Powell, Scientific Reports, 10:2. 2020.
Shortly after publication of this Article in September 2019, the Editors were alerted to concerns regarding the interpretation of the data and some of the conclusions. |
|
|
Transgenic Aedes aegypti Mosquitoes Transfer Genes into a Natural PopulationB. R. Evans, P. Kotsakiozi, A. L. Costa-da-Silva, R. S. Ioshino, L. Garziera, M. C. Pedrosa, A. Malavasi, J. F. Virginio, M. L. Capurro and J. R. Powell, Scientific Reports, 9:6. 2019.
We genotyped the release strain and the target Jacobina population before releases began for >21,000 single nucleotide polymorphisms (SNPs). Genetic sampling from the target population six, 12, and 27-30 months after releases commenced provides clear evidence that portions of the ... |
|
Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmissionA. A. James, J. D. Mumford, S. L. James and Y. T. Touré, WHO/TDR, 2010.
The use of genetically modified mosquitoes (GMMs) for disease control has social, economic and ethical implications, so it is important that the World Health Organization (WHO) and its partners provide guidance to countries on these issues. In collaboration with the Foundation ... |
